BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31568062)

  • 1. Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis.
    Negro A; Graiani G; Nicoli D; Farnetti E; Casali B; Verzicco I; Tedeschi S; Ghirarduzzi A; Cannone V; Marco LDE; Filice A; Gemelli G; Giunta A; Cabassi A
    J Hypertens; 2020 Feb; 38(2):340-346. PubMed ID: 31568062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.
    Pastore Y; Jedlickova K; Guan Y; Liu E; Fahner J; Hasle H; Prchal JF; Prchal JT
    Am J Hum Genet; 2003 Aug; 73(2):412-9. PubMed ID: 12844285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rs779805 Von Hippel-Lindau Gene Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics.
    Remenyi G; Bereczky Z; Gindele R; Ujfalusi A; Illes A; Udvardy M
    Pathol Oncol Res; 2021; 27():1609987. PubMed ID: 34899081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von hippel-lindau disease and erythrocytosis.
    Capodimonti S; Teofili L; Martini M; Cenci T; Iachininoto MG; Nuzzolo ER; Bianchi M; Murdolo M; Leone G; Larocca LM
    J Clin Oncol; 2012 May; 30(13):e137-9. PubMed ID: 22393103
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a new
    Lenglet M; Robriquet F; Schwarz K; Camps C; Couturier A; Hoogewijs D; Buffet A; Knight SJL; Gad S; Couvé S; Chesnel F; Pacault M; Lindenbaum P; Job S; Dumont S; Besnard T; Cornec M; Dreau H; Pentony M; Kvikstad E; Deveaux S; Burnichon N; Ferlicot S; Vilaine M; Mazzella JM; Airaud F; Garrec C; Heidet L; Irtan S; Mantadakis E; Bouchireb K; Debatin KM; Redon R; Bezieau S; Bressac-de Paillerets B; Teh BT; Girodon F; Randi ML; Putti MC; Bours V; Van Wijk R; Göthert JR; Kattamis A; Janin N; Bento C; Taylor JC; Arlot-Bonnemains Y; Richard S; Gimenez-Roqueplo AP; Cario H; Gardie B
    Blood; 2018 Aug; 132(5):469-483. PubMed ID: 29891534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors.
    Gordeuk VR; Sergueeva AI; Miasnikova GY; Okhotin D; Voloshin Y; Choyke PL; Butman JA; Jedlickova K; Prchal JT; Polyakova LA
    Blood; 2004 May; 103(10):3924-32. PubMed ID: 14726398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The homozygous VHL(D126N) missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension.
    Sarangi S; Lanikova L; Kapralova K; Acharya S; Swierczek S; Lipton JM; Wolfe L; Prchal JT
    Pediatr Blood Cancer; 2014 Nov; 61(11):2104-6. PubMed ID: 24729484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis.
    Cario H; Schwarz K; Jorch N; Kyank U; Petrides PE; Schneider DT; Uhle R; Debatin KM; Kohne E
    Haematologica; 2005 Jan; 90(1):19-24. PubMed ID: 15642664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.
    Hudler P; Urbancic M
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.
    Bartels M; van der Zalm MM; van Oirschot BA; Lee FS; Giles RH; Kruip MJ; Gitz-Francois JJ; Van Solinge WW; Bierings M; van Wijk R
    Hum Mutat; 2015 Nov; 36(11):1039-42. PubMed ID: 26224408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W).
    Tomasic NL; Piterkova L; Huff C; Bilic E; Yoon D; Miasnikova GY; Sergueeva AI; Niu X; Nekhai S; Gordeuk V; Prchal JT
    Haematologica; 2013 Apr; 98(4):560-7. PubMed ID: 23403324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Screening Approach for Inherited Erythrocytosis due to the
    Duggal N; Singh N; Sachdev S; Singh AK; Hira JK; Chhabra S; Bansal D; Malhotra P; Varma N; Das R; Sharma P
    Indian J Hematol Blood Transfus; 2023 May; 40(2):1-5. PubMed ID: 37362405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2
    Pang Y; Gupta G; Yang C; Wang H; Huynh TT; Abdullaev Z; Pack SD; Percy MJ; Lappin TRJ; Zhuang Z; Pacak K
    BMC Cancer; 2018 Mar; 18(1):286. PubMed ID: 29534684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the VHL gene in sporadic apparently congenital polycythemia.
    Pastore YD; Jelinek J; Ang S; Guan Y; Liu E; Jedlickova K; Krishnamurti L; Prchal JT
    Blood; 2003 Feb; 101(4):1591-5. PubMed ID: 12393546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer.
    Lanikova L; Lorenzo F; Yang C; Vankayalapati H; Drachtman R; Divoky V; Prchal JT
    Blood; 2013 May; 121(19):3918-24. PubMed ID: 23538339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered cytokine profiles in patients with Chuvash polycythemia.
    Niu X; Miasnikova GY; Sergueeva AI; Polyakova LA; Okhotin DJ; Tuktanov NV; Nouraie M; Ammosova T; Nekhai S; Gordeuk VR
    Am J Hematol; 2009 Feb; 84(2):74-8. PubMed ID: 19062180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemically normal adrenal pheochromocytoma following extensive central necrosis in a child with von Hippel-Lindau (VHL) gene mutation.
    Ng BW; Wong JS; Toh TH
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34937752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas.
    Kang HC; Kim IJ; Park JH; Shin Y; Jang SG; Ahn SA; Park HW; Lim SK; Oh SK; Kim DJ; Lee KW; Choi YS; Park YJ; Lee MR; Kim DW; Park JG
    Oncol Rep; 2005 Oct; 14(4):879-83. PubMed ID: 16142346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.
    Rich TA; Jonasch E; Matin S; Waguespack SG; Gombos DS; Santarpia L; Stolle C; Jimenez C
    Cancer Invest; 2008 Jul; 26(6):642-6. PubMed ID: 18584357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.